A network of high-mobility group box transcription factors programs innate interleukin-17 production

Immunity

Volumn 38, Issue 4, 2013, Pages 681-693

  Malhotra, Nidhi ^a   Narayan, Kavitha ^a   Cho, Ok Hyun ^a   Sylvia, Katelyn E ^a   Yin, Catherine ^a   Melichar, Heather ^a   Rashighi, Mehdi ^a   Lefebvre, Veronique ^b   Harris, John E ^a   Berg, Leslie J ^a   Kang, Joonsoo ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 22; LYMPHOID ENHANCER FACTOR 1; SOX13 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE LOCUS; GENE REGULATORY NETWORK; HIGH MOBILITY GROUP BOX DOMAIN; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; THYMOCYTE;

ANIMALS; ANTIGENS, LY; AUTOANTIGENS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE REGULATORY NETWORKS; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HIGH MOBILITY GROUP PROTEINS; IMMUNITY, INNATE; INTERLEUKIN-17; INTERLEUKINS; INTESTINES; LYMPHOCYTE SUBSETS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; SOXC TRANSCRIPTION FACTORS; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION;

EID: 84876780175     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.01.010     Document Type: Article

References (52)

1. Aliahmad P., de la Torre B., Kaye J. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages. Nat. Immunol. 2010, 11:945-952.
2. Badis G., Berger M.F., Philippakis A.A., Talukder S., Gehrke A.R., Jaeger S.A., Chan E.T., Metzler G., Vedenko A., Chen X., et al. Diversity and complexity in DNA recognition by transcription factors. Science 2009, 324:1720-1723.
3. Brüstle A., Heink S., Huber M., Rosenplänter C., Stadelmann C., Yu P., Arpaia E., Mak T.W., Kamradt T., Lohoff M. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 2007, 8:958-966.
4. Buonocore S., Ahern P.P., Uhlig H.H., Ivanov I.I., Littman D.R., Maloy K.J., Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464:1371-1375.
5. Cai Y., Shen X., Ding C., Qi C., Li K., Li X., Jala V.R., Zhang H.G., Wang T., Zheng J., Yan J. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 2011, 35:596-610.
6. Driskell R.R., Goodheart M., Neff T., Liu X., Luo M., Moothart C., Sigmund C.D., Hosokawa R., Chai Y., Engelhardt J.F. Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. Dev. Biol. 2007, 305:90-102.
7. Felices M., Yin C.C., Kosaka Y., Kang J., Berg L.J. Tec kinase Itk in gammadeltaT cells is pivotal for controlling IgE production in vivo. Proc. Natl. Acad. Sci. USA 2009, 106:8308-8313.
8. Fredriksson T., Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978, 157:238-244.
9. Germar K., Dose M., Konstantinou T., Zhang J., Wang H., Lobry C., Arnett K.L., Blacklow S.C., Aifantis I., Aster J.C., Gounari F. T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc. Natl. Acad. Sci. USA 2011, 108:20060-20065.
10. Gomez-Rodriguez J., Sahu N., Handon R., Davidson T.S., Anderson S.M., Kirby M.R., August A., Schwartzberg P.L. Differential expression of IL-17A and -17F is coupled to TCR signaling via inducible T cell kinase. Immunity 2009, 31:587-597.
11. Haas J.D., Ravens S., Duber S., Sandrock I., Oberdorfer L., Kashani E., Chennupati V., Fohse L., Naumann R., Weiss S., et al. Development of IL-17-Producing γδT Cells Is Restricted to a Functional Embryonic Wave. Immunity 2012, 37:48-59.
12. Huang Z., Xie H., Ioannidis V., Held W., Clevers H., Sadim M.S., Sun Z. Transcriptional regulation of CD4 gene expression by T cell factor-1/β-catenin pathway. J. Immunol. 2006, 176:4880-4887.
13. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
14. Jensen K.D., Su X., Shin S., Li L., Youssef S., Yamasaki S., Steinman L., Saito T., Locksley R.M., Davis M.M., et al. Thymic selection determines γδT cell effector fate: antigen-naive cells make IL-17 and antigen-experienced cells make IFNγ. Immunity 2008, 29:90-100.
15. Kang J., Coles M., Cado D., Raulet D.H. The developmental fate of T cells is critically influenced by TCRgammadelta expression. Immunity 1998, 8:427-438.
16. Laird R.M., Laky K., Hayes S.M. Unexpected role for the B cell-specific Src family kinase B lymphoid kinase in the development of IL-17-producing γδ T cells. J. Immunol. 2010, 185:6518-6527.
17. Lee J.S., Cella M., McDonald K.G., Garlanda C., Kennedy G.D., Nukaya M., Mantovani A., Kopan R., Bradfield C.A., Newberry R.D., Colonna M. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2012, 13:144-151.
18. Lochner M., Peduto L., Cherrier M., Sawa S., Langa F., Varona R., Riethmacher D., Si-Tahar M., Di Santo J.P., Eberl G. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 2008, 205:1381-1393.
19. Luci C., Reynders A., Ivanov I.I., Cognet C., Chiche L., Chasson L., Hardwigsen J., Anguiano E., Banchereau J., Chaussabel D., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 2009, 10:75-82.
20. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 2002, 22:1184-1193.
21. Malhotra N., Robertson E., Kang J. SMAD2 is essential for TGF beta-mediated Th17 cell generation. J. Biol. Chem. 2010, 285:29044-29048.
22. Marfil V., Moya M., Pierreux C.E., Castell J.V., Lemaigre F.P., Real F.X., Bort R. Interaction between Hhex and SOX13 modulates Wnt/TCF activity. J. Biol. Chem. 2010, 285:5726-5737.
23. Melichar H.J., Narayan K., Der S.D., Hiraoka Y., Gardiol N., Jeannet G., Held W., Chambers C.A., Kang J. Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science 2007, 315:230-233.
24. Muranski P., Borman Z.A., Kerkar S.P., Klebanoff C.A., Ji Y., Sanchez-Perez L., Sukumar M., Reger R.N., Yu Z., Kern S.J., et al. Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity 2011, 35:972-985.
25. Narayan K., Sylvia K.E., Malhotra N., Yin C.C., Martens G., Vallerskog T., Kornfeld H., Xiong N., Cohen N.R., Brenner M.B., et al. Intrathymic programming of effector fates in three molecularly distinct γδ T cell subtypes. Nat. Immunol. 2012, 13:511-518. Immunological Genome Project Consortium.
26. O'Brien R.L., Roark C.L., Born W.K. IL-17-producing gammadelta T cells. Eur. J. Immunol. 2009, 39:662-666.
27. Pantelyushin S., Haak S., Ingold B., Kulig P., Heppner F.L., Navarini A.A., Becher B. Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 2012, 122:2252-2256.
28. Penzo-Méndez A., Dy P., Pallavi B., Lefebvre V. Generation of mice harboring a Sox4 conditional null allele. Genesis 2007, 45:776-780.
29. Possot C., Schmutz S., Chea S., Boucontet L., Louise A., Cumano A., Golub R. Notch signaling is necessary for adult, but not fetal, development of RORγt(+) innate lymphoid cells. Nat. Immunol. 2011, 12:949-958.
30. Powolny-Budnicka I., Riemann M., Tänzer S., Schmid R.M., Hehlgans T., Weih F. RelA and RelB transcription factors in distinct thymocyte populations control lymphotoxin-dependent interleukin-17 production in γδ T cells. Immunity 2011, 34:364-374.
31. Qiu J., Heller J.J., Guo X., Chen Z.M., Fish K., Fu Y.X., Zhou L. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012, 36:92-104.
32. Rachitskaya A.V., Hansen A.M., Horai R., Li Z., Villasmil R., Luger D., Nussenblatt R.B., Caspi R.R. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 2008, 180:5167-5171.
33. Reynders A., Yessaad N., Vu Manh T.P., Dalod M., Fenis A., Aubry C., Nikitas G., Escalière B., Renauld J.C., Dussurget O., et al. Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells. EMBO J. 2011, 30:2934-2947.
34. Ribot J.C., deBarros A., Pang D.J., Neves J.F., Peperzak V., Roberts S.J., Girardi M., Borst J., Hayday A.C., Pennington D.J., Silva-Santos B. CD27 is a thymic determinant of the balance between iIFNγ- and IL-17-producing γδT cell subsets. Nat. Immunol. 2009, 10:427-436.
35. Rockman S.P., Currie S.A., Ciavarella M., Vincan E., Dow C., Thomas R.J., Phillips W.A. Id2 is a target of the β-catenin/T cell factor pathway in colon carcinoma. J. Biol. Chem. 2001, 276:45113-45119.
36. Ruan Q., Kameswaran V., Zhang Y., Zheng S., Sun J., Wang J., DeVirgiliis J., Liou H.C., Beg A.A., Chen Y.H. The Th17 immune response is controlled by the Rel-RORγ-RORγ T transcriptional axis. J. Exp. Med. 2011, 208:2321-2333.
37. Sanos S.L., Bui V.L., Mortha A., Oberle K., Heners C., Johner C., Diefenbach A. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 2009, 10:83-91.
38. Satoh-Takayama N., Vosshenrich C.A., Lesjean-Pottier S., Sawa S., Lochner M., Rattis F., Mention J.J., Thiam K., Cerf-Bensussan N., Mandelboim O., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
39. Sawa S., Cherrier M., Lochner M., Satoh-Takayama N., Fehling H.J., Langa F., Di Santo J.P., Eberl G. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 2010, 330:665-669.
40. Schilham M.W., Moerer P., Cumano A., Clevers H.C. Sox-4 facilitates thymocyte differentiation. Eur. J. Immunol. 1997, 27:1292-1295.
41. Shibata K., Yamada H., Nakamura R., Sun X., Itsumi M., Yoshikai Y. Identification of CD25+ gamma delta T cells as fetal thymus-derived naturally occurring IL-17 producers. J. Immunol. 2008, 181:5940-5947.
42. Sinner D., Kordich J.J., Spence J.R., Opoka R., Rankin S., Lin S.C., Jonatan D., Zorn A.M., Wells J.M. Sox17 and Sox4 differentially regulate β-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol. Cell. Biol. 2007, 27:7802-7815.
43. Sonnenberg G.F., Fouser L.A., Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 2011, 12:383-390.
44. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 2011, 12:21-27.
45. Suffia I., Reckling S.K., Salay G., Belkaid Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 2005, 174:5444-5455.
46. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., Littman D.R., O'Shea J.J. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009, 206:35-41.
47. Turchinovich G., Hayday A.C. Skint-1 identifies a common molecular mechanism for the development of IFNγ-secreting versus IL-17-secreting γδT cells. Immunity 2011, 35:59-68.
48. Verbeek S., Izon D., Hofhuis F., Robanus-Maandag E., te Riele H., van de Wetering M., Oosterwegel M., Wilson A., MacDonald H.R., Clevers H. An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 1995, 374:70-74.
49. Vonarbourg C., Mortha A., Bui V.L., Hernandez P.P., Kiss E.A., Hoyler T., Flach M., Bengsch B., Thimme R., Hölscher C., et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity 2010, 33:736-751.
50. Weber B.N., Chi A.W., Chavez A., Yashiro-Ohtani Y., Yang Q., Shestova O., Bhandoola A. A critical role for TCF-1 in T-lineage specification and differentiation. Nature 2011, 476:63-68.
51. Yu Q., Sharma A., Ghosh A., Sen J.M. TCF-1 negatively regulates expression of IL-17 family of cytokines and protects mice from EAE. J. Immunol. 2011, 186:3946-3952.
52. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., Littman D.R. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8:967-974.